More than 17 million treatments are performed globally each year for diabetic foot ulcers (DFU) with half of those becoming infected¹

Repeated courses of antibiotics to treat DFUs risk greater incidences of antimicrobial resistance

US hospitalization costs for infected DFUs: 11,000 to 15,000 USD per patient

The most frequent bacteria associated with DFU include Staphylococcus aureus, Pseudomonas aeruginosa, E. Coli and five other catalase positive microbes

Demonstrated photoinactivation of catalase to enhance bacteria reduction with ROS or ROS generating agents could be instrumental in preventing and treating infected DFUs